Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
15
Number of overlapping holdings
37.5%
% of XPH's 40 holdings also in FTXH
30.0%
% of FTXH's 51 holdings also in XPH
Overlap by Weight
Sector Drift (XPH minus FTXH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XPH |
Weight in FTXH |
Overlap | |
|---|---|---|---|---|
 |
JOHNSON & JOHNSON | 4.1% | 8.1% | 4.1% |
|
ELI LILLY & CO | 4.3% | 3.9% | 3.9% |
|
ZOETIS INC | 3.9% | 3.8% | 3.8% |
|
PFIZER INC | 3.7% | 7.1% | 3.7% |
|
MERCK & CO. INC. | 3.6% | 7.1% | 3.6% |
Position Highlights (Non-Overlapping Exposures)
XPH Overweight Relative to FTXH
|
TARSUS PHARMACEUTICALS, INC. | 4.2% |
|
ROYALTY PHARMA PLC CLASS A | 4.2% |
|
CORCEPT THERAPEUTICS INC | 4.2% |
|
PACIRA PHARMACEUTICALS INC | 3.2% |
|
AXSOME THERAPEUTICS, INC. | 3.2% |
|
PRESTIGE BRANDS HOLDINGS INC | 3.1% |
 |
PERRIGO CO | 2.9% |
|
ARVINAS, INC. | 2.8% |
|
HARMONY BIOSCIENCES HOLDINGS, INC. | 2.8% |
|
AMPHASTAR PHARMACEUTICALS INC | 2.5% |
XPH Underweight Relative to FTXH
|
ABBVIE INC | -7.0% |
|
JOHNSON & JOHNSON | -4.0% |
|
GILEAD SCIENCES INC | -3.9% |
|
AMGEN INC | -3.8% |
|
UNITED THERAPEUTICS CORP | -3.8% |
|
MERCK & CO. INC. | -3.6% |
|
BIOGEN IDEC INC | -3.6% |
|
BRISTOL-MYERS SQUIBB CO | -3.5% |
|
PFIZER INC | -3.4% |
|
REGENERON PHARMACEUTICALS | -3.4% |